Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia

Neurochemical Research

Volumn 27, Issue 10, 2002, Pages 1193-1200

  Hof, Patrick R ^a   Haroutunian, Vahram ^a   Copland, Christina ^a   Davis, Kenneth L ^a   Buxbaum, Joseph D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Microarray; Myelin; Oligodendrocyte; Schizophrenia; Stereology; Therapeutics

Indexed keywords

AGED; ARTICLE; CADAVER; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL LOSS; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIA; PRIORITY JOURNAL; SCHIZOPHRENIA; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN; CELL COUNT; FEMALE; HUMANS; MALE; OLIGODENDROGLIA; REFERENCE VALUES; SCHIZOPHRENIA;

EID: 0036807982     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020981510759     Document Type: Article

References (25)

1. Goldman-Rakic, P. S. and Selemon, L. D. 1997. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23:437-458.
2. Bunney, W. E. and Bunney, B. G. 2000. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31:138-146.
3. Hakak, J., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., and Fienberg, A. A. 2001. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. USA. 98:4746-4751.
4. Barres, B. A. and Raff, M. C. 1999. Axonal control of oligodendrocyte development. J. Cell Biol. 147:1123-1128.
5. Calaora, V., Rogister, B., Bismuth, K., Murray, K., Brandt, H., Leprince, P., Marchionni, M., and Dubois-Dalcq, M. 2001. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro. J. Neurosci. 21:4740-4751.
6. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., and Levitt, P. 2000. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53-67.
7. Mirnics, K., Middleton, F. A., Stanwood, G. D., Lewis, D. A., and Levitt, P. 2001. Disease-specific changes in regulator of G-protein signaling 4 “RGS4” expression in schizophrenia. Mol. Psychiatry 6:293-301.
8. Mirnics, K., Middleton, F. A., Lewis, D. A., and Levitt, P. 2001. Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci. 24:479-486.
9. Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., and Levitt, P. 2002. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22:2719-2729.
10. Vawter, M. P., Barrett, T., Cheadle, C., Sokolov, B. P., Wood, W. H., Donovan, D. M., Webster, M., Freed, W. J., and Becker, K. G. 2001. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55:641-650.
11. Mimmack, M. L., Ryan, M., Baba, H., Navarro-Ruiz, J., Iritani, S., Faull, R. L. M., McKenna P. J., Jones, P. B., Arai, H., Starkey, M., Emson, P. C., and Bahn, S. 2002. Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl. Acad. Sci. USA. 99:4680-4685.
12. Copland, C., Dracheva, S., Davis, K. L., and Haroutunian, V. 2002. mRNA expression of three isoforms of myelin associated glycoprotein “MAG” in patients with schizophrenia. Soc. Neurosci. Abs., in press.
13. Purohit, D. P., Perl, D. P., Haroutunian, V., Powchik, P., Davidson, M., and Davis, K. L. 1998. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: A postmortem neuropathologic study of 100 cases. Arch. Gen. Psychiatry 55:205-211.
14. Perl, D. P., Good, P. F., Bussiere, T., Morrison, J. H., Erwin, J. M., and Hof, P. R. 2000. Practical approaches to stereology in the setting of aging- and disease-related brain banks. J. Chem. Neuroanat. 20:7-19.
15. Nimchinsky, E. A., Young, W. G., Yeung, G., Shah, R. A., Gordon, J. W., Bloom, F. E., Morrison, J. H., and Hof, P. R. 2000. Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice. J. Comp. Neurol. 416:112-125.
16. West, M. J., Slomianka, L., and Gundersen, H. J. G. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 231:482-497.
17. Schmitz, C. and Hof, P. R. 2000. Recommendations for straight-forward and rigorous methods of counting neurons based on a computer simulation approach. J. Chem. Neuroanat. 20:93-114.
18. Miyakawa, T., Sumiyoshi, S., Deshimaru, M., Suzuki, T., and Tomonari, H. “1972” Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol. “Berl.” 20:67-77.
19. Uranova, N., Orlovskaya, D., Vikhreva, O., Zimina, I., Kolomeets, N., Vostrikov, V., and Rachmanova, V. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res. Bull. 55:597-610.
20. Buchsbaum, M. S., Tang, C. Y., Peled, S., Gudbjartsson, H., Lu, D., Hazlett, E. A., Downhill, J., Haznedar, M., Fallon, J. H., and Atlas, S. W. 1998. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9:425-430.
21. Lim, K. O., Hedehus, M., Moseley, M., de Crespigny, A., Sulivan, E. V., and Pfefferbaum, A. “1999” Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch. Gen. Psychiatry 56:367-374.
22. Foong, J., Maier, M., Barker, G. J., Brocklehurst, S., Miller, D. H., and Ron M. A. 2000. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J. Neurol. Neurosurg. Psychiatry 68:70-74.
23. Foong, J., Symms, M. R., Barker, G. J., Maier, M., Woermann, F. G., Miller, D. H., and Ron, M. A. 2001. Neuropathological abnormalities in schizophrenia: Evidence from magnetization transfer imaging. Brain 124:882-892.
24. Benes, F. M. 1989. Myelination of cortical-hippocampal relays during late adolescence. Schizophr. Bull. 15:585-93.
25. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R. P. Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., and Stefansson, K. 2002. Neuregulin I and Susceptibility to Schizophrenia. Am. J. Hum. Genet. 71:877-892.